As of 2025-06-12, the Intrinsic Value of Sonic Healthcare Ltd (SHL.AX) is 21.82 AUD. This SHL.AX valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 26.65 AUD, the upside of Sonic Healthcare Ltd is -18.10%.
The range of the Intrinsic Value is 12.82 - 46.28 AUD
Based on its market price of 26.65 AUD and our intrinsic valuation, Sonic Healthcare Ltd (SHL.AX) is overvalued by 18.10%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 12.82 - 46.28 | 21.82 | -18.1% |
| DCF (Growth 10y) | 17.48 - 54.76 | 27.59 | 3.5% |
| DCF (EBITDA 5y) | 19.22 - 31.46 | 23.32 | -12.5% |
| DCF (EBITDA 10y) | 22.77 - 38.52 | 28.32 | 6.3% |
| Fair Value | 17.66 - 17.66 | 17.66 | -33.74% |
| P/E | 28.99 - 55.50 | 40.22 | 50.9% |
| EV/EBITDA | 22.02 - 34.58 | 27.96 | 4.9% |
| EPV | 46.47 - 67.53 | 57.00 | 113.9% |
| DDM - Stable | 9.30 - 26.14 | 17.72 | -33.5% |
| DDM - Multi | 15.82 - 31.70 | 20.83 | -21.9% |
| Market Cap (mil) | 12,802.66 |
| Beta | 0.66 |
| Outstanding shares (mil) | 480.40 |
| Enterprise Value (mil) | 17,059.61 |
| Market risk premium | 5.10% |
| Cost of Equity | 9.23% |
| Cost of Debt | 5.50% |
| WACC | 7.88% |